top of page

MultiplexDX raised €7.5m from investors

MultiplexDX (Pavol Čekan), which is developing a test for breast cancer, will complete an investment round by the end of the year, raising €7.5m. The money will be provided by existing shareholders including Neulogy Ventures and Crowdberry, as well as new investors. Thanks to high sales of the Covid-19 test, the company reported a €4m net profit in 2021 and used the money to develop the cancer test. It was thus able to skip one investment round.


Táto správa je z Ekonomiky DNES, denného prehľadu najdôležitejších ekonomických správ zo Slovenska.

This news is from the Slovak Business News TODAY, one-page summary of all the important Slovak business news.

bottom of page